These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 6148944)

  • 1. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation.
    Drew R; Miners JO
    Biochem Pharmacol; 1984 Oct; 33(19):2989-94. PubMed ID: 6148944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug metabolizing enzyme changes after chronic buthionine sulfoximine exposure modify acetaminophen disposition in rats.
    Manning BW; Franklin MR; Galinsky RE
    Drug Metab Dispos; 1991; 19(2):498-502. PubMed ID: 1676661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of gamma-glutamylcysteine synthetase large subunit mRNA expression by butylated hydroxyanisole.
    Borroz KI; Buetler TM; Eaton DL
    Toxicol Appl Pharmacol; 1994 May; 126(1):150-5. PubMed ID: 7910420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism of action of paracetamol protective agents in mice in vivo.
    Miners JO; Drew R; Birkett DJ
    Biochem Pharmacol; 1984 Oct; 33(19):2995-3000. PubMed ID: 6487352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of buthionine sulfoximine and diethyl maleate on glutathione turnover in the channel catfish.
    Gallagher EP; Hasspieler BM; Di Giulio RT
    Biochem Pharmacol; 1992 May; 43(10):2209-15. PubMed ID: 1350905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Variable baseline gamma-glutamylcysteine synthetase messenger RNA expression in peripheral mononuclear cells of cancer patients, and its induction by buthionine sulfoximine treatment.
    Yao K; Godwin AK; Ozols RF; Hamilton TC; O'Dwyer PJ
    Cancer Res; 1993 Aug; 53(16):3662-6. PubMed ID: 8101766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-specific changes in glutathione and cysteine after buthionine sulfoximine treatment of rats and the potential for artifacts in thiol levels resulting from tissue preparation.
    Standeven AM; Wetterhahn KE
    Toxicol Appl Pharmacol; 1991 Feb; 107(2):269-84. PubMed ID: 1994510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of glutathione depletion by buthionine sulphoximine on 1-cyano-3,4-epithiobutane toxicity.
    VanSteenhouse JL; Fettman MJ; Gould DH
    Food Chem Toxicol; 1991 Mar; 29(3):153-7. PubMed ID: 2032656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of in utero administration of buthionine sulfoximine on rat development.
    Reyes E; Ott S; Robinson B; Contreras R
    Pharmacol Biochem Behav; 1995 Apr; 50(4):491-7. PubMed ID: 7617692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promotion of trans-platinum in vivo effects on renal heme and hemoprotein metabolism by D,L-buthionine-S,R-sulfoximine. Possible role of glutathione.
    Mayer RD; Maines MD
    Biochem Pharmacol; 1990 May; 39(10):1565-71. PubMed ID: 2337413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buthionine sulfoximine induction of gamma-L-glutamyl-L-cysteine synthetase gene expression, kinetics of glutathione depletion and resynthesis, and modulation of carmustine-induced DNA-DNA cross-linking and cytotoxicity in human glioma cells.
    Ali-Osman F; Antoun G; Wang H; Rajagopal S; Gagucas E
    Mol Pharmacol; 1996 Jun; 49(6):1012-20. PubMed ID: 8649339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous measurements of glutathione and activated sulphate (PAPS) synthesis rates and the effects of selective inhibition of glutathione conjugation or sulphation of acetaminophen.
    Dalhoff K; Poulsen HE
    Biochem Pharmacol; 1993 Aug; 46(3):383-8. PubMed ID: 8347163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation.
    Shrieve DC; Harris JW
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1171-4. PubMed ID: 3744936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA; Greene K; Ahmad S; Vistica DT
    Cancer Res; 1987 Mar; 47(6):1593-7. PubMed ID: 3815359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of modulation of hepatic glutathione on biotransformation and covalent binding of aflatoxin B1 to DNA in the mouse.
    Monroe DH; Eaton DL
    Toxicol Appl Pharmacol; 1988 Jun; 94(1):118-27. PubMed ID: 3131927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Buthionine sulfoximine treatment impairs rat diaphragm function.
    Morales CF; Anzueto A; Andrade F; Brassard J; Levine SM; Maxwell LC; Lawrence RA; Jenkinson SG
    Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):915-9. PubMed ID: 7908245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buthionine sulfoximine inhibition of glutathione biosynthesis enhances hepatic lipid peroxidation in rats during acute ethanol intoxication.
    Kera Y; Ohbora Y; Komura S
    Alcohol Alcohol; 1989; 24(6):519-24. PubMed ID: 2576368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the long-term depletion of reduced glutathione in mice administered L-buthionine-S,R-sulfoximine.
    Sun JD; Ragsdale SS; Benson JM; Henderson RF
    Fundam Appl Toxicol; 1985 Oct; 5(5):913-9. PubMed ID: 2866140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of cyanohydroxybutene on glutathione synthesis in liver and pancreas of male rats.
    Davis MA; Wallig MA; Eaton D; Borroz KI; Jeffery EH
    Toxicol Appl Pharmacol; 1993 Dec; 123(2):257-64. PubMed ID: 7902618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of buthionine sulfoximine (BSO) on mercury distribution after Hg(o) exposure.
    Kim CY; Watanabe C; Satoh H
    Toxicology; 1995 Apr; 98(1-3):67-72. PubMed ID: 7740555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.